Fully Using Agilent High Efficiency Columns with LC/MS

Similar documents
Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR Lipid Cleanup

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Analyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18

Application Note. Abstract. Authors. Pharmaceutical

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

LC/MS/MS Separation of Cholesterol and Related Sterols in Plasma on an Agilent InfinityLab Poroshell 120 EC C18 Column

Removal of Lipids for the Analysis of Toxicological Compounds in Plasma by LC/MS/MS

Application Note. Authors. Abstract. Food

Using Software Tools to Improve the Detection of Impurities by LC/MS. Application Note. Christine Miller Agilent Technologies.

Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

Analytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 120 PFP

Modified QuEChERS for HILIC LC/MS/MS Analysis of Nicotine and Its Metabolites in Fish

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

LC/MS/MS of Trichothecenes and Zearalenone in Wheat Using Different Sample Prep Methods

Quantitative Determination of Drugs of Abuse in Human Whole Blood by LC/MS/MS Using Agilent Captiva EMR Lipid Cleanup

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Identification of Steroids in Water by Ion Trap LC/MS/MS Application

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Application Note. Author. Abstract. Introduction. Food Safety

Increasing resolution using longer columns while maintaining analysis time Advantages of the wide power range of the Agilent 1290 Infinity LC System

Evaluation of UHPLC System Performance Under High Throughput Conditions. William Hedgepeth, Masatoshi Takahashi, Shimadzu Scientific Instruments

Comparison of a UPLC Method across Multiple UHPLC Systems

Author. Introduction. Small Molecule Pharmaceuticals & Generics

Supporting Information

Selectivity Comparison of Agilent Poroshell 120 Phases in the Separation of Butter Antioxidants

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

New HPLC Column Options for UHPLC

Cannabinoid Quantitation Using an Agilent 6430 LC/MS/MS

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Determination of Benzodiazepines in Urine by CE-MS/MS

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Detection, Confirmation, and Quantification of Chloramphenicol in Honey, Shrimp and Chicken Using the Agilent 6410 LC/MS Triple Quadrupole

Fat-Soluble Vitamins Analysis on an Agilent ZORBAX Eclipse PAH Polymeric C18 Bonded Column

Quantitative Analysis of Underivatized Amino Acids in Plant Matrix by Hydrophilic Interaction Chromatography (HILIC) with LC/MS Detection

High-Resolution Analysis of Intact Triglycerides by Reversed Phase HPLC Using the Agilent 1290 Infinity LC UHPLC System

High Resolution Glycopeptide Mapping of EPO Using an Agilent AdvanceBio Peptide Mapping Column

Direct Analysis of Folic Acid in Digestive Juices by LC/TOF-MS Application

Analyze Drugs of Abuse with Agilent J&W Ultimate Plus Tubing in an Inert Flow Path

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

The LC Column Playbook

Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System

Application Note. Small Molecule Pharmaceuticals. 2-Ethyl-2-phenylmalonamide Ethosuximide Primidone Carbamazepine. Carbamazepine-

Opiates, Opioids and Benzodiazepines, Amphetamines & Illicit Drug Forensic Analysis by LC/MS

Authors. Abstract. Introduction. Environmental

Toxicology Screening of Whole Blood Extracts Using GC/Triple Quadrupole/MS

Author. Introduction. Abstract

The Raptor HILIC-Si Column

Authors. Abstract. Forensic Toxicology. Irina Dioumaeva, John M. Hughes Agilent Technologies, Inc.

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Analysis of mycotoxins in food matrices using the Agilent Ultivo Triple Quadrupole LC/MS

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Transferring a Method for Analysis of DNPH-Derivatized Aldehydes and Ketones from HPLC to UHPLC

Agilent 6470 Triple Quadrupole LC/MS System and EMR-Lipid. The Combination for Confident Pesticide Quantitation. Christoph Mueller

Advancing your Forensic Toxicology Analyses; Adopting the Latest in Mass Spectrometry Innovations

Performance Characteristics of the Agilent 1290 Infinity II Multicolumn Thermostat

Two-Dimensional LC/MS/MS to Reduce Ion Suppression in the Determination of Cannabinoids in Blood Plasma

Mycotoxin Analysis in Peanut Butter Using Captiva EMR Lipid Cleanup and LC/MS/MS

Overview. Introduction. Experimental. Cliquid Software for Routine LC/MS/MS Analysis

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Maximizing Efficiency Using Agilent InfinityLab Poroshell 120 Columns

Agilent 6410 Triple Quadrupole LC/MS. Sensitivity, Reliability, Value

Am I getting the very best value from my UHPLC analyses?

Separation of Polyphenols by Comprehensive 2D-LC and Molecular Formula Determination by Coupling to Accurate Mass Measurement

Converting a CHP Method for Insulin to Agilent Poroshell 120 Columns

Maximizing chromatographic peak capacity with the Agilent 1290 Infinity LC system

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Determination of Amantadine Residues in Chicken by LCMS-8040

2D-LC as an Automated Desalting Tool for MSD Analysis

11:00 a.m. EST Telephone Number: Chair Person: Tim Spaeder

Application. Authors. Abstract. Introduction. Forensics

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Edgar Naegele. Abstract

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Modernizing the Forensic Lab with LC-MS/MS Technology

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

Agilent 6490 Triple Quadrupole LC/MS System with ifunnel Technology. Ultra sensitive quantitative performance

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

Mycotoxin Analysis in Infant Formula Using Captiva EMR Lipid Cleanup and LC/MS/MS

A Novel HILIC Column for High Speed N-linked Glycan Analysis

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Determination of Multi-Residue Tetracyclines and their Metabolites in Milk by High Performance Liquid Chromatography - Tandem Mass Spectrometry

Determination of Selected Illegal Drugs and its Important Metabolites in Waste Water by Large Volume Direct Injection HPLC-MS/MS

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Determination of Opiates and Metabolites in Blood Using Electrospray LC/MS. Application Note

Identification of Imidacloprid Metabolites in Onions Using High Resolution Accurate Mass Spectrometry (LC/Q-TOF MS) and Accurate Mass Tools

Determination of Sulfonamide Antibiotics in Bovine Liver Using Agilent Bond Elut QuEChERS EN Kits by LC/MS/MS

Determination of Aflatoxins in Food by LC/MS/MS. Application. Authors. Abstract. Experimental. Introduction. Food Safety

Transfer and Speed-up of Methods to Fused-Core Particle Columns EPA Method 1694

Analysis of Amino Acids Derived Online Using an Agilent AdvanceBio AAA Column

A FORENSIC TOXICOLOGY METHOD FOR THE DETERMINATION OF DESOMORPHINE, HEROIN, METHADONE, BUPRENORPHINE AND METABOLITES IN URINE USING LC/MS QQQ

Transcription:

Fully Using gilent High Efficiency Columns with LC/MS Technical Overview bstract dvancements in liquid chromatography, such as UHPLC and LC/MS, require that special care is taken when optimizing method parameters. Various applications will show the effects of different mobile phases using MS detection with respect to ion suppression, and how particle size and data collection rates affect MS performance, with consideration to both sensitivity and peak capacity. Introduction New columns with smaller particles sizes, including both sub 2-μm and superficially porous 2 3 μm columns, improve LC productivity by providing more resolution and more analysis speed. The same types of columns can be used for LC/MS applications. Many questions arise on the compatibility of these columns with LC/MS and the options for increasing productivity. The first questions focus on adequate detector speed with the MS, as well as how fast and how many compounds can be adequately resolved for the MS. dditional questions focus on obtaining good peak shape with LC/MS compatible mobile phases. Various application examples will be used to compare columns with different particle sizes and demonstrate that adequate detector speed is available to take advantage of the high efficiency possible with these columns. dditional considerations around mobile phase and peak shape for optimal LC/MS results will be shown.

Experimental n gilent 2 Rapid Resolution LC (RRLC) System, an gilent 29 Infinity LC System, and an gilent G64 Triple Quadrupole Mass Spectrometer were used in this experiment. The MS was used in a variety of modes (including Scan, SIM, MRM) to illustrate the detection improvements possible over a range of analytical methods utilizing MS detection. ll connecting capillaries had a small.2 mm id in the shortest possible lengths to ensure minimal loss of efficiency through extra column volume and sample band broadening. Detailed method parameters are shown with their respective chromatograms. Conditional peak capacity will be used to evaluate the different method parameters. Peak capacity is the number of peaks that can be theoretically separated over a gradient time, see Equation. Equation. Conditional peak capacity = = t R,n t R, t R,n and t R, : Retention times of the last and first eluting peaks : /2: Conditional Peak Capacity /2 4 (verage 4s peak width) 2.3 is the average peak width at half height. Results and Discussion Different particle sizes with MS detection common misconception regarding LC/MS is that small particle columns lose their advantages over slightly larger particle columns because of sample band broadening due to increased extra-column volume with the MS detector. Figure shows that this is not the case. hile it is true that some of the small particle s advantages are muted, they still exist. This example shows a separation of analgesic compounds analyzed independently with either UV or MS detection. The detectors are not connected in series, as this would immediately put the MS at a disadvantage due to band broadening that would occur in the diode array detector's flow cell as the sample travels through to the MS source. It is shown that when upgrading from a 3. μm column to a.8 μm column, with UV detection, a 37% increase in peak capacity is realized, however, only a 26% increase in peak capacity is seen with MS detection. Even though the extra volume in the mass spectrometer neutralizes some of the benefits of smaller particles, there is still a noticeable improvement with the high efficiency column. 2

mu 7 3 UV Detector gilent ZORX Eclipse Plus C8 3. mm mm, 3. μm ve /2 =.2 = 4 7 6 4 Counts 3 2 MS Detector gilent ZORX Eclipse Plus C8 3. mm mm, 3. μm ve /2 =. = 43 mu 7 3 gilent ZORX RRHD Eclipse Plus C8 3. mm mm.8 μm ve /2 =.84 = 74.2..7.2..7 7 gilent ZORX RRHD Eclipse Plus C8 6 3. mm mm,.8 μm ve 4 /2 =.2 n 3 c = 4 2 Counts min.2.4.6.8..2.4.6.8 Instrument gilent 29/64 LC/MS/MS.2% formic acid in water acetonitrile Flow rate ml/min T. % 9 Stop time 2 min Post run time. min Sample 2 μl injection of μg/ml standard in water TCC mbient, no temperature control (approx 24 C) DD Sig = 26, 4 nm; Ref = Off Source ESI+, 3 C, 2 L/min, psi, 3 V Fragmentor 3 V Scan 4, ms scan time.2 amu step, 28.36 cycles/s 3.3 ms/cycle Compounds (in elution order) with identifying mass: acetaminophen: m/z 9 caffeine: m/z 94 2-acetamidophenol: m/z 9 acetanilide: m/z 3 acetylsalicylic acid: m/z 2 phenacetin: m/z 79 salicylic acid: m/z 2 sulindac: m/z 36 piroxicam: m/z 332 tolmetin: m/z 27 ketoprofen: m/z 24 diflunisal: m/z 332 diclofenac: m/z 29 celecoxib: m/z 38 ibuprofen: m/z 6 Figure. Comparison of 3. versus.8 μm performance with UV and MS scan detection. Refer to gilent Publication 99-8428EN for more information regarding this specific application. 3

Knowing that the advantages of smaller particles can be seen with MS detection, four different particle sizes are compared in Figure 2 with a complex, 2 compound toxicology analysis using LC/MS/MS. The top chromatogram shows a superficially porous 2.7 μm, while the following three chromatograms show tra itional totally porous particles that are.8, 3., and μm respectively. The three totally porous particles all share the same bonding chemistry, while the superficially porous particles have very similar chemistry; the result is nearly identical selectivity across the four analyses. Immediately, the disadvantages of the μm column with such a complex analysis are evident. ith the μm column, all peaks are much more broad than with the three smaller particle sizes, and there is abundant coelution of peaks, particularly with the early eluting compounds. In this toxicology example, the differences among the 2.7,.8, and 3. μm columns appear more subtle. The 3. μm column produces slightly wider peaks across the gradient, while the 2.7 and.8 μm columns are more comparable. The larger 2.7 μm superficially porous columns are capable of similar performance to the smaller.8 μm totally porous particles due to their narrower particle size distribution and thin porous shells with a short mass transfer distance.

2.2 gilent Poroshell 2 EC-C8, 2. mm, 2.7 μm.8 /2 =.39 /2 =.49 /2 =.38.6.4 /2 =.44.2 /2 =.38.8.2.4.6.8 2 2.2 2.4 2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8.2.4.6 Counts Counts Counts Counts 2 gilent ZORX RRHT Eclipse Plus C8, 2. mm,.8 μm.8 /2 =.4 /2 =.38.6 /2 =.49.4 /2 =.43.2 /2 =.37.8.2.4.6.8 2 2.2 2.4 2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8.2.4.6 2.2 gilent ZORX Eclipse Plus C8, 2. mm, 3. μm.8 /2 =.4 /2 =. /2 =.47.6.4 /2 =.47 /2 =.38.2.8.2.4.6.8 2 2.2 2.4 2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8.2.4.6 x 2 gilent ZORX Eclipse Plus C8, 2. mm, μm.8.4.6 /2 =.6 /2 =.69 /2 =.99.2 /2 =.82 /2 =.62.8.2.4.6.8 2 2.2 2.4 2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8.2.4.6 Instrument Flow rate Figure 2. gilent 2/64 LC/MS/MS mm ammonium formate w/.% formic acid acetonitrile w/.% formic acid. ml/min T. 3. 4. 6. % 9 9 Stop time 6 min Post run time 2 min Sample μl injection of gilent LC/MS Toxicology Test Mixture (p/n 9-47), diluted : in water TCC 6 C MS 3 C, 2 L/min, 3 psi, 2 V, P-ESI+, dmrm Compounds in elution order: codeine oxycodone amphetamine MD hydrocodone methamphetamine MDM strychnine phentermine MDE heroin cocaine meperidine trazodone PCP oxazepam nitrazepam verapamil lorazepam methadone alprazolam temazepam proadifen diazepam THC Comparison of superficially porous 2.7 μm and totally porous, 3., and.8 μm performance with MS/MS detection. Refer to gilent Publication 99-634EN for more information regarding this specific application.

Figure 3 shows a closer comparison of 2.7,.8, and 3. μm columns, with a more simplified analysis of common analgesic compounds. gain, the very similar selectivity across the three columns is apparent. This feature of gilent s LC column family is advantageous for laboratories that require transferability among their methods. s shown by the pressures on the left side of the chromatograms, the 3. μm column would be ideal for performing this analysis on a 4 bar HPLC, while the gilent Poroshell 2 column would work best on a 6 bar instrument, and the.8 μm column is beneficial for a > 6 bar UHPLC. Conditional peak capacity on the smaller particle columns is > 2% higher than the 3. μm column. lso, sensitivity (signal-to-noise) is greatly improved by more than 4% with the taller sharper peaks on the.8 and 2.7 μm columns, as compared to the 3. μm. 6

7.8 2.6.4.2.8.6.4.2 Counts Counts Counts 7 2.4 2.2.8 2.6.4.2.8.6.4.2 7 2.2.8 2.6.4.2.8.6.4.2 Instrument gilent 29/64 LC/MS/MS.2% formic acid in water acetonitrile Flow rate ml/min T. % 9 Stop time 2 min Post run time. min Sample 2 μl injection of μg/ml standard in water TCC mbient, no temperature control (approx 24 C) Source ESI+, 3 C, 2 L/min, psi, 3 V Fragmentor 3 V Scan 4, ms scan time,.2 amu step, 28.36 cycles/s, 3.3 ms/cycle Compounds (in elution order) with Identifying Mass: acetaminophen: m/z 9 caffeine: m/z 94 2-acetamidophenol: m/z 9 acetanilide: m/z 3 acetylsalicylic acid: m/z 2 Figure 3. gilent ZORX Eclipse Plus C8, 3 mm, 3. μm P max = 2 bar phenacetin: m/z 79 salicylic acid: m/z 2 sulindac: m/z 36 piroxicam: m/z 332 tolmetin: m/z 27 ketoprofen: m/z 24 diflunisal: m/z 332 diclofenac: m/z 29 celecoxib: m/z 38 ibuprofen: m/z 6 Comparison of superficially porous 2.7 μm and totally porous 3. and.8 μm performance with MS scan detection. Refer to gilent Publication 99-8428EN for more information regarding this specific application..873..2.3.4..6.7.8.9..2.3.4..6.7.8.9 gilent ZORX RRHD Eclipse Plus C8, 3 mm,.8 μm P max = 647 bar.84..2.3.4..6.7.8.9..2.3.4..6.7.8.9 gilent Poroshell 2 EC-C8, 3 mm, 2.7 μm P max = 466 bar.829..2.3.4..6.7.8.9..2.3.4..6.7.8.9 Ibuprofen P /2 =.4 S/N = 82 = 43 Ibuprofen P /2 =.2 S/N = 33 = 4 Ibuprofen P /2 =.2 S/N = 26 = 6 7

ecause the highly efficient.8 and 2.7 μm columns outperform the 3. μm column by so much, shorter columns may be used, as seen in Figure 4. Comparing mm,.8 and 2.7 μm columns to a mm, 3. μm column at the same flow rate, results in half the analysis time for the.8 and 2.7 μm columns. The result is similar peak capacity for all three analyses. Therefore, the.8 and 2.7 μm columns can theoretically separate the same number of peaks in half the time of the 3. μm column. Pressure is also noteworthy in this example, as the Poroshell 2, mm column generates similar pressure to the mm, 3. μm column, each well under 4 bar, so these analyses could be run on any LC system. hen pressure is not an issue, the gilent ZORX RRHD Eclipse Plus C8 mm,.8 μm columan be pushed to over bar, resulting in an 8% reduction in analysis time, as compared to the original mm, 3. μm analysis. hile some peak capacity is lost, and coelution occurs for such a fast analysis, the highly selective MS detector can still manage ample resolving power for these analgesics in.4 min. It should be noted that using this G64 MS with an ESI source at 2.7 ml/min is not considered a good practice. In this example flow rate was increased to demonstrate ample scan rate by the MS under extreme conditions, however, this is not a practice that should be used with this MS. Newer technologies like the gilent Jet Stream Thermal Gradient Focusing Technology with ESI source can be used to extend the flow rate range beyond 2 ml/min without deleterious effects on the analysis. For more information refer to gilent Publication 99-3494EN. 8

7 2 Counts Counts Counts Counts.. 7.8.6.4.2 6 6 4 3 2 6 3 2 gilent ZORX Eclipse Plus C8 3 mm, 3. μm ml/min 2 bar.873..2.3.4..6.7.8.9...2.3.4..6.7.8.9 2. gilent ZORX RRHD Eclipse Plus C8 3 mm,.8 μm ml/min 22 bar..2.3.4..6.7.8.9. gilent Poroshell 2 EC-C8 3 mm, 2.7 μm ml/min 26 bar verage P /2 =.2 = 43 verage P /2 =.92 = 39..2.3.4..6.7.8.9. gilent ZORX RRHD Eclipse Plus C8 3 mm,.8 μm 2.7 ml/min 72 bar.369....2.2.3.3.4.6 verage P /2 =.86 = 43.997 verage P /2 =. = 26 Instrument Sample TCC Source Fragmentor Scan Compounds (in elution order) with Identifying Mass: acetaminophen: m/z 9 caffeine: m/z 94 2-acetamidophenol: m/z 9 acetanilide: m/z 3 acetylsalicylic acid: m/z 2 gilent 29/64 LC/MS/MS.2% formic acid in water acetonitrile 2 μl ( μl for mm column) injection of μg/ml standard mbient, no temperature control (approx 24 C) ESI+, 3 C, 2 L/min, psi, 3 V 3 V 4, ms scan time,.2 amu step, 28.36 cycles/s, 3.3 ms/cycle 3 mm, ml/min, 9% in. min 3 mm, ml/min, 9% in.7 min 3 mm, 2.7 ml/min, 9% in.27 min phenacetin: m/z 79 salicylic acid: m/z 2 sulindac: m/z 36 piroxicam: m/z 332 tolmetin: m/z 27 ketoprofen: m/z 24 diflunisal: m/z 332 diclofenac: m/z 29 celecoxib: m/z 38 ibuprofen: m/z 6 Figure 4. Example of high speed analysis possible with superficially porous 2.7 μm and totally porous.8 μm versus 3. μm with MS detection. Refer to gilent Publication 99-8428EN for more information regarding this specific application. 9

practical example of what better peak capacity can do for an analysis is illustrated in Figure. Here is an overlay of a blank whole blood extract with a spiked whole blood extract. ecause the gilent Poroshell 2 column produces such sharp peaks and consequently high peak capacity, it can separate the analytes from the background peaks in the sample matrix. Occasionally, coeluting peaks can suppress the signal of one or both of the compounds, therefore the best protection against this ion suppression is to separate all peaks chromatographically. 7 Counts.3.2..9.8.7.6..4.3.2 LCK: hole blood background (blank) RED: Spiked sample, compounds, 2 ng/ml each Naloxone Diltiazam, Oxazepam Lorazepam. 2 3 4 6 7 8 9 Instrument: Flow rate Figure. gilent 2/646 LC/MS/MS mm mmonium acetate, ph ; 2:8 Methanol: ater mm mmonium cetate in cetonitrile.4 ml/min T. 7. % 2 7 7 Sample μl injection of whole blood extract Column gilent Poroshell 2 EC-C8 2. mm, 2.7 μm Source 4 C, 2 L/min, 4 psi, 3 V Fragmentor 8 V MS Scan mass range 8 Scan time 2 sec ESI Positive polarity QuEChERS extraction of whole blood: -ml aliquot of whole blood was added to a centrifuge tube and spiked with appropriate volume from a concentrated stock mixture to yield 2 ng/ml of the component mix, added 2 μl of IS stock solution (nortriptyline), two ceramic homogenizers, then vortexed. Then 2 ml of acetonitrile solutions (with or without acid) was added and vortexed. premixed amount of the extraction salts was added and vigorously shaken, centrifuged at rpm for min. One milliliter of the extract was transferred into a d-spe tube (2 ml centrifuge tube) containing mg of PS and mg of MgSO 4 for matrix cleanup; vortexed for min and centrifuged at 8, rpm for 3 min. 2 μl aliquot of the extract was transferred into a LC vial containing 8 μl of water, vortexed and analyzed. Separation of analytes from whole blood sample matrix background with a highly efficient superficially porous 2.7 μm column and MS scan detection.

UV Data collection rate MS scan rate Optimizing data collection rates with MS to balance sensitivity and peak capacity The tea analysis in Figure 6, shown on an gilent ZORX RRHD S-C8 column illustrates the effects of various data collection rates ohromatographic quality, including UV, MS scan, MS SIM, and MS/MS detection modes. Using Equation, the conditional peak capacity of this analysis is compared alongside signal-to-noise calculations for each chromatogram. In all cases, the same patteran be seen. The mass spectrometer has more than enough speed for data collection than it needs for this analysis, to the point where negative effects are shown with faster data collection rates when too many data points are collected. The fastest data collection rates generate the narrowest peaks, resulting in the highest peak capacity; however, the fastest data collection rates also generate the most baseline noise, which decreases the signal-to-noise ratio. hen sensitivity is the most important factor of an analysis, a slightly slower data collection rate should be used; though this will decrease the conditional peak capacity. dditionally regarding sensitivity is the X improvement in signal-to-noise wheomparing MS scan to MS/MS detection. MS SIM dwell time MS/MS dmrm Cycle time mu.2 s 3 6 2 ms 6 ms 6 ms P /2 =.22 P /2 =.8 P /2 =.24 P 2 /2 =.24 S/N = 27 S/N = 39 S/N = 3..2..7.2..7 min mu.2 s 6 ms 6 ms 8 ms P /2 =.22 3 P /2 =.8 P /2 =.24 P /2 =.27 S/N = 278 2 S/N = 43 S/N = 98..2..7.2..7 min mu. s 6 ms 6 2 ms ms P /2 =.23 3 P /2 =.9 P /2 =.27 P /2 =.3 S/N = 388 2 S/N = 86 S/N = 74..2..7.2..7 min mu. s 2 ms 6 ms 6 2 ms 3 P /2 =.2 P /2 =.3 P /2 =.39 P /2 =.28 2 S/N = 72 S/N = 8 S/N = 744..2..7.2..7 min ms 6 7 ms mu 2. s ms P 3 /2 =.42 6 P /2 =.49 P /2 =. P /2 =. S/N = 9 S/N = 277 2 S/N = 2389..2..7.2..7 min.2.4.6.8.2.4.6.8.2.4.6.8.2.4.6.8.2.4.6.8.2.4.6.8 Instrument gilent 29/64 LC/MS/MS.2% acetic acid in water acetonitrile Flow rate ml/min T. 2 % 27 Stop time 2 min Post run time 2 min Sample μl injection of 6 μg/ml standard in water TCC 4 C Column gilent ZORX RRHD S-C8 2. mm,.8 μm DD Sig = 2, 4nm; Ref = Off Source ESI+, 3 C, L/min, psi, 3 V MS, Pos SIM 7, 37, 9, 29, 49, 443 dmrm transitions (Fragmentor = 3 V) Gallic acid 7 & 9, 27 (CE=) (Epi)gallocatechin 37 & 39, 2 (CE=) (Epi)catechin 29 & 39,23 (CE=) Caffeine 9 & 38, (CE=3) (Epi)gallocatechin gallate 49 & 39, 289 (CE=) (Epi)catechin gallate 443 & 39, 23 (CE=4) Figure 6. Comparison of detector data collection rates with UV, MS scan, MS SIM and MS/MS with a.8 μm column. Refer to gilent Publication 99-7824EN for more information regarding this specific pplication.

Peak capacity and baseline separation are not always the most important factors to mass spectrometrists. However, in analyses like this, there are four epimer pairs that are detected by the same mass unit, which must be baseline separated for accurate, reproducible quantitation; most notably are the last two peaks, epicatechin gallate (ECG) and catechin gallate (CG) which elute closely and share m/z 443 as their mass. Figure 7 shows a rapid analysis with more than adequate MS detector speed of catechins in tea where the epimer pairs are shown in matching colors; the black peak pair eluting around.9 min is the critical pair of this analysis. ith the highly efficient gilent Poroshell 2 column used for this analysis, all peaks can be baseline separated in min, a feat that would likely not be possible with a slightly larger 3. μm column. P max = 8 bar....2.2.3.3.4.4...6.6.7.7.8.8.9 Instrument gilent 2/64 LC/MS/MS.2% acetic acid in water acetonitrile Flow rate. ml/min T.36.7 % 27 Stop time min Post run time. min Sample. μl injection of 3 μg/ml standard in water TCC 4 C Column gilent Poroshell 2 S-C8 2. mm, 2.7 μm DD Sig = 2, 4 nm; Ref = Off Source ESI+, 3 C, L/min, psi, ± 3 V Fragmentor 3 V MS, SIM- (69, 3, 289, 47, 44), SIM+ (9) Sample: Gallic acid: m/z 7 (Epi)gallocatechin: m/z 37 (Epi)catechin: m/z 29 Caffeine: m/z 9 (Epi)gallocatechin gallate: m/z 49 (Epi)catechin gallate: m/z 443 Figure 7. Example of fast MS scan analysis possible with a highly efficient superficially porous 2.7 μm column. Refer to gilent Publication 99-7824EN for more information regarding this specific application. 2

Figure 8 shows an ultra fast separation of analgesic compounds in.4 minutes on an RRHD Eclipse Plus C8 column. s with Figure 7, the MS is fast enough to collect enough data points across all peaks, even iases with coeluting peaks. The total iohromatogram (TIC) on top shows several partially coeluting peaks, particularly around tolmetin, shown with the red arrow. ecause each compound is identified by a unique mass, extracted iohromatograms (EICs) allow the analyst to view each component separately, as seen with just the EIC of m/z 27 for tolmetin in the bottom chromatogram. Viewing EICs separately allows for simple integration and quantification of any compound. gain, it should be noted that using this G64 MS with an ESI source at 2.7 ml/min is not recommended. The flow rate was increased to demonstrate sufficient scan rate by the MS under extreme conditions. hen increased throughput is needed, the new gilent Jet Stream Thermal Gradient Focusing Technology with ESI source can be used to extend the flow rate range beyond 2 ml/min without negatively impacting the analysis. For more information refer to gilent Publication 99-3494EN. Counts 6 3 2.2 6 3 Counts Counts 2 6.. TIC Scan P max =72 bar.2.4.6.8..2.4.6.8.2.22.24.26.28.3.32.34.36.38.4 EIC overlay of all compounds.2.4.6.8..2.4.6.8.2.22.24.26.28.3.32.34.36.38.4.33 Individual EIC of m/z 27 (tolmetin).33. Figure 8..2.4.6.8..2.4.6.8.2.22.24.26.28.3.32.34.36.38.4 Instrument gilent 29/64 LC/MS/MS.2% formic acid in water acetonitrile Flow rate 2.7 ml/min T.27 Source ESI+, 3 C, 2 L/min, psi, 3 V % 9 Fragmentor 3 V Stop time.4 min Scan 4, ms scan time,.2 amu step, Post run time.27 min 28.36 cycles/s, 3.3 ms/cycle Sample μl injection of μg/ml standard in water TCC mbient, no temperature control (approx 24 C) Column gilent ZORX RRHD Eclipse Plus C8 3 mm,.8 μm Compounds (in elution order) with Identifying Mass: acetaminophen: m/z 9 caffeine: m/z 94 2-acetamidophenol: m/z 9 acetanilide: m/z 3 Example of ultra fast MS scan analysis possible with a highly efficient.8 μm column. Refer to gilent Publication 99-8428EN for more information regarding this specific application. 3 acetylsalicylic acid: m/z 2 phenacetin: m/z 79 salicylic acid: m/z 2 sulindac: m/z 36 piroxicam: m/z 332 tolmetin: m/z 27 ketoprofen: m/z 24 diflunisal: m/z 332 diclofenac: m/z 29 celecoxib: m/z 38 ibuprofen: m/z 6

Optimizing sensitivity by selecting the best MS mobile phase Figure 9 shows several MS-friendly mobile phases that were screened for use with a tea analysis on an gilent Poroshell 2 S-C8 column. Selectivity and peak shape remained constant regardless of the mobile phase used, consequently, the optimal mobile phase was selected based on signal strength of the analytes. Significant ion suppression is present with the ammonium acetate buffer, as well as with the trifluoroacetic acid mobile phase. The two best contenders were formic and acetic acid, with acetic acid producing a slightly more intense signal. Comparing the most sensitive acetic acid mobile phase to the least sensitive ammonium acetate mobile phase shows that the sensitivity of the acetic acid was five times the sensitivity of the ammonium acetate. 2. 2 Counts. 2. 2..2% HCOOH.2% CH 3 COOH.2% CF 3 COOH mm CH 3 COONH 4, ph 3.6 (adjusted to ph with mm CH 3 COOH) S/N = S/N = S/N = 68 S/N = 33..3..7.9..3..7.9 2. 2.3 2. 2.7 2.9 3. 3.3 3. Instrument gilent 2/64 LC/MS/MS acidified water acetonitrile Flow rate.729 ml/min T.43 2.86 % 27 Stop time 3.6 min Post run time.7 min Sample 3 μl injection of 3 μg/ml standard in water TCC 4 C Column gilent Poroshell 2 S-C8 2. mm, 2.7 μm DD Sig = 2, 4 nm: Ref = Off Source ESI+, 3 C, L/min, psi, ± 3 V Fragmentor 3 V MS, SIM- (69, 3, 289, 47, 44), SIM+ (9) Sample: Gallic acid: m/z 7 (Epi)gallocatechin: m/z 37 (Epi)catechin: m/z 29 Caffeine: m/z 9 (Epi)gallocatechin gallate: m/z 49 (Epi)catechin gallate: m/z 443 Figure 9. Comparison of the effect of mobile phase on signal-to-noise (S/N) with a superficially porous 2.7 μm column and MS scan detection. Refer to gilent Publication 99-7824EN for more information regarding this specific application. 4

Conclusions Small particle size columns, including sub-2 μm and superficially porous 2 3 μm, enhance LC/MS (Scan and SIM) and LC/MS/MS results. Improvements in sensitivity, resolution and peak capacity are observed, as compared to 3. and μm columns with MS detection. High efficiency columns are particularly useful when samples contain isomers that require baseline resolution for accurate quantitation, or when samples are iomplex matrices and separation from the background is desirable to avoid the possibility of ion suppression with coeluting peaks. dditionally, mobile phase considerations should be taken with MS detection to prevent ion suppression and optimize for analyte peak shape, selectivity and sensitivity.

www.agilent.com/chem gilent shall not be liable for errors contained herein or for incidental or consequential damages ionnection with the furnishing, performance, or use of this material. Information, descriptions, and specifications in this publication are subject to change without notice. gilent Technologies, Inc., 22 Printed in the US 99-8623EN For Forensic Use.